Inventor · disambiguated record
John F. Mcelroy
Also filed as: MCELROY JOHN F · MCELROY JOHN FRANCIS
33 granted patents·5 pending applications·219 citations·filing 1992–2020
96Inventor score
Files withMCELROY JOHN F14JENRIN DISCOVERY9JENRIN DISCOVERY INC5MCELROY JOHN FRANCIS4JENRIN DISCOVERY LLC2
Top patents by PatentIndex Score
38 records- 0196US7655685B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY INC·Filed 2008·Granted Feb 2, 2010·51 cites·58 claims
- 0293US8133904B2Cannabinoid receptor antagonists/inverse agonists useful for treating obesityMCELROY JOHN F·Filed 2008·Granted Mar 13, 2012·26 cites·14 claims
- 0393US7482470B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY INC·Filed 2007·Granted Jan 27, 2009·21 cites·336 claims
- 0492US9987253B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY·Filed 2016·Granted Jun 5, 2018·8 cites·19 claims
- 0592US9517228B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY·Filed 2015·Granted Dec 13, 2016·8 cites·18 claims
- 0691US8088809B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2010·Granted Jan 3, 2012·13 cites·272 claims
- 0791US7666889B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY INC·Filed 2008·Granted Feb 23, 2010·15 cites·336 claims
- 0890US8138216B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2009·Granted Mar 20, 2012·11 cites·36 claims
- 0989US7687481B2Cannabinoid receptor antagonists/inverse agonists useful for treating obesityJENRIN DISCOVERY INC·Filed 2007·Granted Mar 30, 2010·13 cites·32 claims
- 1085US8334282B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2010·Granted Dec 18, 2012·8 cites·19 claims
- 1185US8236821B2Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesityMCELROY JOHN F·Filed 2009·Granted Aug 7, 2012·5 cites·12 claims
- 1280US8580768B2Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2011·Granted Nov 12, 2013·5 cites·20 claims
- 1379US7119196B2Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2003·Granted Oct 10, 2006·12 cites·5 claims
- 1478US8680131B2Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancersJENRIN DISCOVERY·Filed 2013·Granted Mar 25, 2014·2 cites·19 claims
- 1578US8252791B2Purine compounds as cannabinoid receptor blockersMCELROY JOHN F·Filed 2009·Granted Aug 28, 2012·3 cites·30 claims
- 1677US8138209B2Substituted picolinamides as MAO-B inhibitors useful for treating obesityMCELROY JOHN FRANCIS·Filed 2006·Granted Mar 20, 2012·5 cites·20 claims
- 1772US8853252B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2012·Granted Oct 7, 2014·1 cites·29 claims
- 1871US6486173B25-HT7 receptor antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Nov 26, 2002·4 cites·15 claims
- 1969US11179370B2Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancersJENRIN DISCOVERY LLC·Filed 2020·Granted Nov 23, 2021·0 cites·20 claims
- 2069US8217038B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2010·Granted Jul 10, 2012·1 cites·96 claims
- 2165US10617673B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY LLC·Filed 2018·Granted Apr 14, 2020·0 cites·18 claims
- 2265US9133127B2Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancersJENRIN DISCOVERY·Filed 2014·Granted Sep 15, 2015·0 cites·18 claims
- 2362US2015157605A1Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY·Filed 2014·Application pending·0 cites
- 2461US8541475B2MAO-B inhibitors useful for treating obesityMCELROY JOHN FRANCIS·Filed 2009·Granted Sep 24, 2013·0 cites·246 claims
- 2556US2013005784A1Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRIN DISCOVERY·Filed 2011·Application pending·0 cites
- 2654US8088926B2Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesityMCELROY JOHN F·Filed 2008·Granted Jan 3, 2012·0 cites·36 claims
- 2754US7759335B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesJENRM DISCOVERY INC·Filed 2009·Granted Jul 20, 2010·0 cites·26 claims
- 2854US7649115B2MAO-B inhibitors useful for treating obesityJENRIN DISCOVERY INC·Filed 2006·Granted Jan 19, 2010·0 cites·72 claims
- 2952US7956220B2MAO-B inhibitors useful for treating obesityJENRIN DISCOVERY·Filed 2006·Granted Jun 7, 2011·0 cites·708 claims
- 3051US2014155355A1Mao-b inhibitors useful for treating obesityJENRIN DISCOVERY·Filed 2013·Application pending·0 cites
- 3150US8648072B2Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetesMCELROY JOHN F·Filed 2012·Granted Feb 11, 2014·0 cites·96 claims
- 3250US2007078172A1Mao-b inhibitors useful for treating obesityJENRIN DISCOVERY·Filed 2006·Application pending·0 cites
- 3349US8124802B2MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesityMCELROY JOHN F·Filed 2008·Granted Feb 28, 2012·0 cites·14 claims
- 3449US2012015909A1Mao-b inhibitors useful for treating obesityMCELROY JOHN FRANCIS·Filed 2011·Application pending·0 cites
- 3545US6239143B15-HT7 receptor antagonistsDU PONT PHARM CO·Filed 1999·Granted May 29, 2001·2 cites·15 claims
- 3643US8088798B2Cannabinoid receptor antagonists/inverse agonists useful for treating obesityMCELROY JOHN FRANCIS·Filed 2010·Granted Jan 3, 2012·0 cites·25 claims
- 3740US8716265B24-quinolinemethanols as anti-malarial agentsMCELROY JOHN F·Filed 2011·Granted May 6, 2014·0 cites·48 claims
- 3831US5308405AToilet bowl cleaning systemMCELROY JOHN F·Filed 1992·Granted May 3, 1994·5 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when John F. Mcelroy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →